Abstract

The World Health Organization (WHO) declared the COVID-19 infection a pandemic on January 30, 2020. This extraordinary calamity has had a devastating influence on all facets of human life, leading to an enormous rise in mortality and morbidity rates, the disruption of the healthcare system, and the addition of new costs on communities Co-morbid conditions such hypertension, cardiovascular disease, diabetes, and cerebrovascular disease have been linked to higher rates and more severe COVID-19 infections, a larger need for hospitalisation, and other negative outcomesintense care, and worse disease-related outcomes [1-15]. Results of a comprehensive review and metaanalysis revealed that co-morbidities were present in 40.80% of the affected individuals. While diabetes is more common in fatal cases compared to total cases (24.89%), hypertension is associated with more severe and fatal cases (47.65% and 47.90%, respectively).One of the most significant comorbidities is diabetes, which is documented in 5–36% of COVID-19 patients After adjusting for confounders, patients with diabetes have a 100–250 percent higher chance of developing serious sequelae and dying from COVID-19 than those without diabetes.

Lockdown and social isolation may have an influence on daily life, routine medical care, and the treatment of chronic illnesses like diabetes. The COVID-19 epidemic can have indirect negative effects on the diagnosis, prevalence, and self-management of the disease due to changes in how the healthcare system functions, social support, and patients' regular lifestyles and health behaviours, in addition to direct negative effects on mortality and morbidity in patients with diabetes. These negative effects include dietary modifications and the intake of high-calorie meals, encouragement of a sedentary lifestyle, inadequate sleep, an increase in social and economic issues, and challenging access to medical facilities and pharmacies.